• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLOS Glob Public Health . Seroprevalence of SARS-CoV-2 antibodies in Bali Province: Indonesia shows underdetection of COVID-19 cases by routine surv

tetano

Editor, Senior Moderator
PLOS Glob Public Health


. 2022 Aug 31;2(8):e0000727.
doi: 10.1371/journal.pgph.0000727. eCollection 2022.
Seroprevalence of SARS-CoV-2 antibodies in Bali Province: Indonesia shows underdetection of COVID-19 cases by routine surveillance


Anak A S Sawitri[SUP] 1 [/SUP], Putu C D Yuliyatni[SUP] 1 [/SUP], Putu A S Astuti[SUP] 1 [/SUP], Emita Ajis[SUP] 2 3 [/SUP], Endang B Prasetyowati[SUP] 2 3 [/SUP], Husni[SUP] 4 [/SUP], Juliette Morgan[SUP] 5 [/SUP], Jennifer Mika[SUP] 5 [/SUP], Catharina Y Praptiningsih[SUP] 5 [/SUP], Amalya Mangiri[SUP] 5 [/SUP], Ester Mulyadi[SUP] 5 [/SUP], Rintis Noviyanti[SUP] 6 [/SUP], Leily Trianty[SUP] 6 [/SUP], William A Hawley[SUP] 5 [/SUP]



Affiliations
Free PMC article

Abstract

The international tourist destination of Bali reported its first case of Coronavirus Disease 2019 or COVID-19 in March 2020. To better understand the extent of exposure of Bali's 4.3 million inhabitants to the COVID-19 virus, we performed two repeated cross-sectional serosurveys stratified by urban and rural areas. We used a highly specific multiplex assay that detects antibodies to three different viral antigens. We also assessed demographic and social risk factors and history of symptoms. Our results show that the virus was widespread in Bali by late 2020, with 16.73% (95% CI 12.22-21.12) of the population having been infected by that time. We saw no differences in seroprevalence between urban and rural areas, possibly due to extensive population mixing, and similar levels of seroprevalence by gender and among age groups, except for lower seroprevalence in the very young. We observed no difference in seroprevalence between our two closely spaced surveys. Individuals reporting symptoms in the past six months were about twice as likely to be seropositive as those not reporting symptoms. Based upon official statistics for laboratory diagnosed cases for the six months prior to the survey, we estimate that for every reported case an additional 52 cases, at least, were undetected. Our results support the hypothesis that by late 2020 the virus was widespread in Bali, but largely undetected by surveillance.
 
Back
Top Bottom